Search research articles
Contact Us
Filters
Showing results (181-190 of 229) with videos related to
Page
of 23
Sort By:
Medical Oncology (Northwood, London, England)
|
July 8, 2011
Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement
C Porta, G Tortora, C Linassier, et al.
La Medicina Del Lavoro
|
February 7, 2006
Malignant mesothelioma in 2004: How advanced technology and new drugs are changing the perspectives of mesothelioma patients. Highlights from the VIIth Meeting of the International Mesothelioma Interest Group
C Porta, A Ardizzoni, G Gaudino, et al.
Haematologica
|
August 28, 2001
A rapid D-dimer assay in patients presenting at the emergency room with suspected acute venous thrombosis: accuracy and relation to clinical variables
S Siragusa, V Terulla, S Pirrelli, et al.
Hepato-Gastroenterology
|
March 13, 1998
Catheter seeding of hepatocellular carcinoma following placement of a total implantable access port system
M Alessiani, L Vai, V Jemos, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
July 5, 2020
In vivo effects of the association of the psychoactive phenotiazine thioridazine on antitumor activity and hind limb paralysis induced by the native polypeptide crotamine
Lucas C Porta, Joana D Campeiro, Giovanna B Papa, et al.
International Nursing Review
|
June 3, 2020
Nursing practice and global refugee migration: initial impressions from an Intergovernmental-Academic Partnership
V Bampoh, M Thongkhamkitcharoen, S Dicker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 27, 2001
SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma
P Cacciotti, R Libener, P Betta, et al.
Medical Oncology (Northwood, London, England)
|
September 17, 2009
Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET
S Negrier, E Jäger, C Porta, et al.
Minerva Medica
|
February 28, 1985
[Surgical treatment of thoracic and abdominal esophageal cancer. Author's experience from 1950 to 1982. Evolution of management and methods]
T Rock, G Emanuelli, S De Fina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 2009
Malignant peritoneal mesothelioma: a multicenter study on 81 cases
V de Pangher Manzini, L Recchia, M Cafferata, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 229) with videos related to
Sort By:
Page
of 23
Medical Oncology (Northwood, London, England)
|
July 8, 2011
Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement
C Porta, G Tortora, C Linassier, et al.
La Medicina Del Lavoro
|
February 7, 2006
Malignant mesothelioma in 2004: How advanced technology and new drugs are changing the perspectives of mesothelioma patients. Highlights from the VIIth Meeting of the International Mesothelioma Interest Group
C Porta, A Ardizzoni, G Gaudino, et al.
Haematologica
|
August 28, 2001
A rapid D-dimer assay in patients presenting at the emergency room with suspected acute venous thrombosis: accuracy and relation to clinical variables
S Siragusa, V Terulla, S Pirrelli, et al.
Hepato-Gastroenterology
|
March 13, 1998
Catheter seeding of hepatocellular carcinoma following placement of a total implantable access port system
M Alessiani, L Vai, V Jemos, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
July 5, 2020
In vivo effects of the association of the psychoactive phenotiazine thioridazine on antitumor activity and hind limb paralysis induced by the native polypeptide crotamine
Lucas C Porta, Joana D Campeiro, Giovanna B Papa, et al.
International Nursing Review
|
June 3, 2020
Nursing practice and global refugee migration: initial impressions from an Intergovernmental-Academic Partnership
V Bampoh, M Thongkhamkitcharoen, S Dicker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 27, 2001
SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma
P Cacciotti, R Libener, P Betta, et al.
Medical Oncology (Northwood, London, England)
|
September 17, 2009
Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET
S Negrier, E Jäger, C Porta, et al.
Minerva Medica
|
February 28, 1985
[Surgical treatment of thoracic and abdominal esophageal cancer. Author's experience from 1950 to 1982. Evolution of management and methods]
T Rock, G Emanuelli, S De Fina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 2009
Malignant peritoneal mesothelioma: a multicenter study on 81 cases
V de Pangher Manzini, L Recchia, M Cafferata, et al.
Page
of 23